A) Geodon B) Risperdal C) Prolixin D) Zyprexa
A) Clozaril B) Zyprexa C) Invega D) Abilify
A) Seroquel B) Abilify C) Invega D) Zyprexa
A) Abilify B) Seroquel C) Zyprexa D) Risperdal
A) Risperdal B) Geodon C) Abilify D) Seroquel
A) Quetiapine B) Clozapine C) Ziprasidone D) Olanzapine
A) Ziprasidone B) Aripriprazole C) Paliperidone D) Risperidone
A) Clozaril B) Risperdal C) Seroquel D) Geodon
A) Paliperidone B) Ziprasidone C) Clozapine D) Aripiprazole
A) Risperdone B) Paliperidone C) Olazapine D) Quetiapine
A) Aripiprazole and Paliperidone B) Clozapine and Aripiprazole C) Risperidone and Paliperidone D) Clozapine and Risperadone
A) 1-3 B) 2-5 C) 4-5 D) 1
A) 12 B) 18 C) 24 D) 6
A) TRUE B) FALSE
A) Minimize side effects of medication B) Foster patients' medication compliance C) Prevent relapse into another psychotic episode D) Develop more adaptive coping skills
A) directly after discontinuation of medication B) six months after discontinuation of medication C) one year after discontinuation of medication D) several weeks after discontinuation of medication
A) Thorazine B) Clozaril C) Artane D) Symmetrel
A) weight gain more common B) increased effectiveness for positive, negative, and disorganized symptoms C) tardive dyskinesia more common D) enhanced efficacy in treatment-resistant patients
A) Clozapine B) Prochlorperazine C) Haloperiodol D) Risperidone
A) Anticonvulsants B) Anxiolitics C) Stimulants D) Alcohol
A) Merperidine B) Alcohol C) Beta blockers D) Halperiodol
A) Anticonvulsants B) Nicotine C) Beta blockers D) Antacids
A) Alcohol B) SSRIs C) Tricyclic antidepressants D) Beta blockers
A) FALSE B) TRUE
A) Male gender B) Tobacco use C) Alcohol use D) Drug holidays
A) FALSE B) TRUE
A) High potency antipsychotic drugs present greater risk for the development of tardive dyskinesia. B) All antipsychotic drugs but Clozapine present a significant risk for the development of tardive dyskinesia. C) Classic antipsychotic medications present less risk for the development of tardive dyskinesia than atypical antipsychotic medications. D) The more frequent the dose of the antipsychotic medication, the greater the risk for the development of tardive dyskinesia.
A) Ataxia B) Akathesia C) Akinesia D) Acute dystonia
A) Gynecomastia B) Postural hypotension C) Agranulocytosis D) Neuroleptic Malignant Syndrome
A) TRUE B) FALSE
A) TRUE B) FALSE
A) block D2 receptors in the pituitary gland and decrease prolactin secretion. B) block D2 receptors in the pituitary gland and inhibit prolactin secretion. C) agonize the normal dopamine-mediated inhibition of prolactin release. D) antagonize the normal dopamine-mediated inhibition of prolactin release.
A) hungry hungry hippos B) molecular structure C) receptor binding and DA turnover D) neuroendocrine changes
A) Butyrophenones B) Phenothiazines C) Thioxanthenenes D) Sleepykoaladones
A) Potent; low; higher B) Potent; low; lower C) Weak; high; lower D) Weak; high; higher
A) Delusions B) Hallucinations C) Formal thought disorder D) Anhedonia
A) Autoimmune diseases B) All of the above C) Endocrine disorders D) Neurological disorders E) Metabolic disorders
A) Alcohol B) All of the above C) Opioids D) Hallucinogens E) Stimulants
A) FALSE B) TRUE
A) disorganized symptoms of Schizophrenia. B) positive symptoms of Schizophrenia. C) All of the above. D) negative symptoms of Schizophrenia.
A) blocking post-synaptic dopamine receptors and/or inhibiting dopamine release. B) blocking pre-synaptic dopamine receptors and/or inhibiting dopamine release. C) blocking post-synaptic dopamine receptors and/or inhibiting dopamine reuptake. D) blocking pre-synaptic dopamine receptors and/or inhibiting dopamine reuptake.
A) the drug reduces the normal dopamine-mediated activity in the striatum, which then reduces the cholinergic response that is normally inhibited by dopamine. B) the drug increases the normal dopamine-mediated activity in the striatum, which then reduces the cholinergic response that is normally inhibited by dopamine. C) the drug reduces the normal dopamine-mediated activity in the striatum, which then enhances the cholinergic response that is normally inhibited by dopamine. D) the drug increases the normal dopamine-mediated activity in the striatum, which then enhances the cholinergic response that is normally inhibited by dopamine.
A) increased rates of firing B) increased tap dancing C) increased rates of synthesis D) increased release of dopamine
A) piperideines B) thioxanthenes C) piperazines D) aliphatics
A) galactorrhea B) menstrual irregularity C) genecomastia D) all of the above
A) Cogentin (benztropine) B) Inapsine (droperiodol) C) Symmetrel (amantadine) D) Artane (trihexphenidyl) E) Benadryl (diphenhydramine)
A) FALSE B) TRUE
A) actual impact at the biological level B) polypharmacy C) comparative lack of EPS D) superior impact on positive symptoms
A) Clozaril B) Abilify C) Invega D) Haldol
A) Geodon B) Clorazil C) Seroquel D) Risperdal |